| Logo | Name | Σ |
|---|---|---|
 | Greater Paris University Hospitals - AP-HP Nous soignons et innovons 365 jours par an. AP-HP (Greater Paris University Hospitals) is a European world-renowned university hospital. Its 39 hospitals treat 8 million people every year: in consultation, emergency, during scheduled or home hospitalizations. The AP-HP provides a public health service for everyone, 24 hours a day. This mission is a duty as well as a great source of pride. AP-HP is the leading employer in the Greater Paris area: 100.000 staff members – doctors, researchers, paramedical staff, administrative personnel and workers – work there. Toutes les spécialités médicales de la néonatologie à la gériatrie en passant par … Sectors: Health | 2260 |
 | EY EY is building a better working world by creating new value for clients, people, society, the planet, while building trust in the capital markets. Enabled by data, AI and advanced technology, EY teams help clients shape the future with confidence and develop answers for the most pressing issues of today and tomorrow. EY teams in more than 150 countries work across a full spectrum of services in assurance, consulting, tax, strategy and transactions, strengthened by sector experience and diverse ecosystem partners. Find out more about the EY global network: http://ey.com/en_gl/legal-statement Advisory, Assurance, Tax, Transactions, Audit, Mergers, M&A, Financial Services, Accounting, … Sectors: Consulting, audit | 5927 |
 | 21 | Croix-Rouge française 21 is the social innovation accelerator of the French Red Cross and Nexem The accelerator of social innovation, 21, a platform of resources and actors which makes possible solutions with high impact. | 260 |
 | Institut Analgesia 1st foundation of pain research in France A major public health problem, chronic pain today affects 1 out of 5 adults, or more than 12 million French people. And as the therapeutic arsenal is both aging and insufficient, almost 2 thirds of patients believe that their pain is insufficiently controlled. Pain also has a very important impact on occupational health. Dorsal pain is the 1st cause of incapacity in the world and musculoskeletal disorders represent the 1st cause of occupational disease in France. The pain in itself impacts 88 million working days per year in France. Fighting pain is therefore … Sectors: Research | 184 |
 | Handicap.fr Handicap.fr, information and services, from disability to autonomy! Our commitment: - Inform all the people concerned by disability - Promote the employment of disabled people thanks to their digital fairs Hello-handicap.fr and its job section. http://pro.hello-handicap.fr - contribute to the full recognition of people with disabilities as a citizen The site was opened on September 2, 2002. Handicap, technical assistance, employment, information, diversity, and autonomy Sectors: NGO, Think Tank | 401 |
 | Direction Générale des Entreprises The DGE designs and implements policies in favor of the competitiveness and growth of businesses. The Directorate General of Companies is at the service of the Minister responsible for the Economy and Finance. Our action is at the heart of government projects in favor of economic transformation and the country's strategic autonomy. At the service of business competitiveness, it brings industrial policy, defines digital regulation measures, as well as policies for supporting the local economy. It supports companies in the digital and ecological transformation of the economy, and works in favor of regulatory simplification and an ambitious innovation policy. Its … Sectors: National and local authorities | 1733 |
 | Startup Palace We Run Accelerators Startup Palace is not an accelerator. Nor an incubator. Startup Palace “does not” startup accelerators. Startup Palace goes beyond. Startup Palace helps large companies to transform themselves by making them collaborate with innovative startups, via project acceleration programs. We are convinced on the one hand that large companies cannot innovate alone and that they need startups to transform. And on the other hand, that startups cannot grow alone, that they need experimentation grounds to confront their solutions to the reality on the ground, to find their first customers and thus generate turnover. Doing it with corporates who … Sectors: Startup accelerator & VC | 578 |
 | grandlyon A moving administration is a whole city that moves #vilDelyon! Capital of the Rhône-Alpes region, Lyon is one of the most attractive cities in Europe for its quality of life and its exceptional economic dynamism. At the heart of the Lyon metropolis, the city of Lyon (500,000 inhabitants) has a global budget of 780 million euros and a workforce of 7,300 permanent agents allowing it to offer a local public service to the population with a constant concern for quality. Do you want to discover our professions, inform yourself about recruitment methods or apply for our job offers? Go to … | 2191 |
 | CNRS The French National Centre for Scientific Research is among the world's leading research institutions. Its scientists explore the living world, matter, the Universe, and the functioning of human societies in order to meet the major challenges of today and tomorrow. Internationally recognised for the excellence of its scientific research, the CNRS is a reference in the world of research and development, as well as for the general public. Recherche scientifique, Biologie, Chimie, Ecologie et environnement, Ingénierie et systèmes, Mathématiques, Physique, Sciences de l'information, Homme et société, Nucléaire et particules, Terre et Univers, and Science Sectors: Research | 3439 |
 | KLESIA Insurer of general interest Klesia is committed by providing prevention, persons and simple, innovative, united and sustainable insurance solutions, adapted to your needs and those of your loved ones, throughout life. We also manage additional retirement for AGIRC-Arrco by collecting contributions, calculating retirement points, analyzing retirement request files and paying pensions of more than 2 million retirees. Beyond our initial trades, we act for the most fragile, work to age better and help make health accessible to all. Klesia undertakes to ensure a serene future and contributes to the quality of life for all. To formalize this societal commitment, Klesia … Sectors: Insurance | 721 |
 | Bayer Bayer is a global enterprise with core competencies in the life science fields of healthcare and nutrition. We design our products and services to serve the most essential human needs of health and nutrition. At the same time, we strive to address some of the world’s biggest challenges presented by a growing and aging global population. At Bayer, we’re committed to driving sustainable development and generate a positive impact with our businesses. Through the power of science, we’re pioneering new possibilities that advance life for all of us. That means reimagining how we care for ourselves and one another by … Tags: DAX30 Sectors: Chemistry Pharmaceutical | 4846 |
 | Groupe APICIL The Apicil group is the 3rd French social protection group. Joint and mutualist, the group was created by and for companies and employees. Gouted by its customers, the group is, like them, anchored in economic life. Apicil knows them, shares and understands their issues, priorities and constraints. More than 2,100 employees thus support 2.2 million insured by offering them lasting, efficient and adapted solutions to protect them throughout their health, foresight, savings, financial and retirement services. At the heart of its consulting and insurance missions, the Apicil group improves the overall performance of companies by contributing to the health and … Sectors: Health Insurance Mutual insurance | 510 |
 | Amgen #WeareBiotech Amgen harnesses the best of biology and technology to fight the world’s toughest diseases, and make people’s lives easier, fuller and longer. We helped establish the biotechnology industry, and we remain on the cutting-edge of innovation, using technology and human genetic data to push beyond what’s known today. Our investment in research and development has yielded a robust pipeline that builds on our existing portfolio of medicines to treat cancer, heart disease, osteoporosis, inflammatory diseases and rare diseases. Amgen is one of 30 companies comprising the Dow Jones Industrial Average®, and part of the Nasdaq-100 Index®. In 2024, Amgen … Sectors: Biotechnology | 1655 |